Report Detail

Electronics & Semiconductor Global Human Organs-on-Chips Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM3818432
  • |
  • 25 July, 2023
  • |
  • Global
  • |
  • 110 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Electronics & Semiconductor

According to our (Global Info Research) latest study, the global Human Organs-on-Chips market size was valued at USD 90 million in 2022 and is forecast to a readjusted size of USD 563 million by 2029 with a CAGR of 29.9% during review period.
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Global key players of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health and CN Bio Innovations. The top five players hold a share over 55%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately. In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.
The Global Info Research report includes an overview of the development of the Human Organs-on-Chips industry chain, the market status of Pharmaceutical & Biotechnology Companies (Brain-on-a-chip, Liver-on-a-chip), Academic & Research Institutes (Brain-on-a-chip, Liver-on-a-chip), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Organs-on-Chips.
Regionally, the report analyzes the Human Organs-on-Chips markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Organs-on-Chips market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Organs-on-Chips market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Organs-on-Chips industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Brain-on-a-chip, Liver-on-a-chip).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Organs-on-Chips market.
Regional Analysis: The report involves examining the Human Organs-on-Chips market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Organs-on-Chips market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Organs-on-Chips:
Company Analysis: Report covers individual Human Organs-on-Chips players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Organs-on-Chips This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Human Organs-on-Chips. It assesses the current state, advancements, and potential future developments in Human Organs-on-Chips areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Organs-on-Chips market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Organs-on-Chips market is split by Type and by End User. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.
Market segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Market segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Market segment by players, this report covers
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Organs-on-Chips product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Organs-on-Chips, with revenue, gross margin and global market share of Human Organs-on-Chips from 2018 to 2023.
Chapter 3, the Human Organs-on-Chips competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Human Organs-on-Chips market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Organs-on-Chips.
Chapter 13, to describe Human Organs-on-Chips research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Human Organs-on-Chips
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Human Organs-on-Chips by Type
    • 1.3.1 Overview: Global Human Organs-on-Chips Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Human Organs-on-Chips Consumption Value Market Share by Type in 2022
    • 1.3.3 Brain-on-a-chip
    • 1.3.4 Liver-on-a-chip
    • 1.3.5 Kidney-on-a-chip
    • 1.3.6 Lung-on-a-chip
    • 1.3.7 Heart-on-a-chip
    • 1.3.8 Intestine-on-a-chip
    • 1.3.9 Vessel-on-a-chip
    • 1.3.10 Other Organs
  • 1.4 Global Human Organs-on-Chips Market by End User
    • 1.4.1 Overview: Global Human Organs-on-Chips Market Size by End User: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical & Biotechnology Companies
    • 1.4.3 Academic & Research Institutes
    • 1.4.4 Cosmetics Industry
    • 1.4.5 Others
  • 1.5 Global Human Organs-on-Chips Market Size & Forecast
  • 1.6 Global Human Organs-on-Chips Market Size and Forecast by Region
    • 1.6.1 Global Human Organs-on-Chips Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Human Organs-on-Chips Market Size by Region, (2018-2029)
    • 1.6.3 North America Human Organs-on-Chips Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Human Organs-on-Chips Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Human Organs-on-Chips Market Size and Prospect (2018-2029)
    • 1.6.6 South America Human Organs-on-Chips Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Human Organs-on-Chips Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Emulate
    • 2.1.1 Emulate Details
    • 2.1.2 Emulate Major Business
    • 2.1.3 Emulate Human Organs-on-Chips Product and Solutions
    • 2.1.4 Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Emulate Recent Developments and Future Plans
  • 2.2 Mimetas
    • 2.2.1 Mimetas Details
    • 2.2.2 Mimetas Major Business
    • 2.2.3 Mimetas Human Organs-on-Chips Product and Solutions
    • 2.2.4 Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Mimetas Recent Developments and Future Plans
  • 2.3 TissUse
    • 2.3.1 TissUse Details
    • 2.3.2 TissUse Major Business
    • 2.3.3 TissUse Human Organs-on-Chips Product and Solutions
    • 2.3.4 TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 TissUse Recent Developments and Future Plans
  • 2.4 Valo Health
    • 2.4.1 Valo Health Details
    • 2.4.2 Valo Health Major Business
    • 2.4.3 Valo Health Human Organs-on-Chips Product and Solutions
    • 2.4.4 Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Valo Health Recent Developments and Future Plans
  • 2.5 CN Bio Innovations
    • 2.5.1 CN Bio Innovations Details
    • 2.5.2 CN Bio Innovations Major Business
    • 2.5.3 CN Bio Innovations Human Organs-on-Chips Product and Solutions
    • 2.5.4 CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 CN Bio Innovations Recent Developments and Future Plans
  • 2.6 Hesperos
    • 2.6.1 Hesperos Details
    • 2.6.2 Hesperos Major Business
    • 2.6.3 Hesperos Human Organs-on-Chips Product and Solutions
    • 2.6.4 Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Hesperos Recent Developments and Future Plans
  • 2.7 Draper Laboratory
    • 2.7.1 Draper Laboratory Details
    • 2.7.2 Draper Laboratory Major Business
    • 2.7.3 Draper Laboratory Human Organs-on-Chips Product and Solutions
    • 2.7.4 Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Draper Laboratory Recent Developments and Future Plans
  • 2.8 Nortis
    • 2.8.1 Nortis Details
    • 2.8.2 Nortis Major Business
    • 2.8.3 Nortis Human Organs-on-Chips Product and Solutions
    • 2.8.4 Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Nortis Recent Developments and Future Plans
  • 2.9 Micronit Microtechnologies B.V.
    • 2.9.1 Micronit Microtechnologies B.V. Details
    • 2.9.2 Micronit Microtechnologies B.V. Major Business
    • 2.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Solutions
    • 2.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Micronit Microtechnologies B.V. Recent Developments and Future Plans
  • 2.10 Kirkstall
    • 2.10.1 Kirkstall Details
    • 2.10.2 Kirkstall Major Business
    • 2.10.3 Kirkstall Human Organs-on-Chips Product and Solutions
    • 2.10.4 Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Kirkstall Recent Developments and Future Plans
  • 2.11 Cherry Biotech SAS
    • 2.11.1 Cherry Biotech SAS Details
    • 2.11.2 Cherry Biotech SAS Major Business
    • 2.11.3 Cherry Biotech SAS Human Organs-on-Chips Product and Solutions
    • 2.11.4 Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Cherry Biotech SAS Recent Developments and Future Plans
  • 2.12 Else Kooi Laboratory
    • 2.12.1 Else Kooi Laboratory Details
    • 2.12.2 Else Kooi Laboratory Major Business
    • 2.12.3 Else Kooi Laboratory Human Organs-on-Chips Product and Solutions
    • 2.12.4 Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Else Kooi Laboratory Recent Developments and Future Plans
  • 2.13 Altis Biosystems
    • 2.13.1 Altis Biosystems Details
    • 2.13.2 Altis Biosystems Major Business
    • 2.13.3 Altis Biosystems Human Organs-on-Chips Product and Solutions
    • 2.13.4 Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Altis Biosystems Recent Developments and Future Plans
  • 2.14 Bi/ond
    • 2.14.1 Bi/ond Details
    • 2.14.2 Bi/ond Major Business
    • 2.14.3 Bi/ond Human Organs-on-Chips Product and Solutions
    • 2.14.4 Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Bi/ond Recent Developments and Future Plans
  • 2.15 Netri
    • 2.15.1 Netri Details
    • 2.15.2 Netri Major Business
    • 2.15.3 Netri Human Organs-on-Chips Product and Solutions
    • 2.15.4 Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Netri Recent Developments and Future Plans
  • 2.16 Xona Microfluidics
    • 2.16.1 Xona Microfluidics Details
    • 2.16.2 Xona Microfluidics Major Business
    • 2.16.3 Xona Microfluidics Human Organs-on-Chips Product and Solutions
    • 2.16.4 Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Xona Microfluidics Recent Developments and Future Plans
  • 2.17 SynVivo
    • 2.17.1 SynVivo Details
    • 2.17.2 SynVivo Major Business
    • 2.17.3 SynVivo Human Organs-on-Chips Product and Solutions
    • 2.17.4 SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 SynVivo Recent Developments and Future Plans
  • 2.18 Beijing Daxiang Biotech
    • 2.18.1 Beijing Daxiang Biotech Details
    • 2.18.2 Beijing Daxiang Biotech Major Business
    • 2.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Product and Solutions
    • 2.18.4 Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Beijing Daxiang Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Human Organs-on-Chips Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Human Organs-on-Chips by Company Revenue
    • 3.2.2 Top 3 Human Organs-on-Chips Players Market Share in 2022
    • 3.2.3 Top 6 Human Organs-on-Chips Players Market Share in 2022
  • 3.3 Human Organs-on-Chips Market: Overall Company Footprint Analysis
    • 3.3.1 Human Organs-on-Chips Market: Region Footprint
    • 3.3.2 Human Organs-on-Chips Market: Company Product Type Footprint
    • 3.3.3 Human Organs-on-Chips Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Human Organs-on-Chips Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Human Organs-on-Chips Market Forecast by Type (2024-2029)

5 Market Size Segment by End User

  • 5.1 Global Human Organs-on-Chips Consumption Value Market Share by End User (2018-2023)
  • 5.2 Global Human Organs-on-Chips Market Forecast by End User (2024-2029)

6 North America

  • 6.1 North America Human Organs-on-Chips Consumption Value by Type (2018-2029)
  • 6.2 North America Human Organs-on-Chips Consumption Value by End User (2018-2029)
  • 6.3 North America Human Organs-on-Chips Market Size by Country
    • 6.3.1 North America Human Organs-on-Chips Consumption Value by Country (2018-2029)
    • 6.3.2 United States Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Human Organs-on-Chips Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Human Organs-on-Chips Consumption Value by Type (2018-2029)
  • 7.2 Europe Human Organs-on-Chips Consumption Value by End User (2018-2029)
  • 7.3 Europe Human Organs-on-Chips Market Size by Country
    • 7.3.1 Europe Human Organs-on-Chips Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 7.3.3 France Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Human Organs-on-Chips Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Organs-on-Chips Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Human Organs-on-Chips Consumption Value by End User (2018-2029)
  • 8.3 Asia-Pacific Human Organs-on-Chips Market Size by Region
    • 8.3.1 Asia-Pacific Human Organs-on-Chips Consumption Value by Region (2018-2029)
    • 8.3.2 China Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 8.3.5 India Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Human Organs-on-Chips Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Human Organs-on-Chips Consumption Value by Type (2018-2029)
  • 9.2 South America Human Organs-on-Chips Consumption Value by End User (2018-2029)
  • 9.3 South America Human Organs-on-Chips Market Size by Country
    • 9.3.1 South America Human Organs-on-Chips Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Human Organs-on-Chips Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Organs-on-Chips Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Human Organs-on-Chips Consumption Value by End User (2018-2029)
  • 10.3 Middle East & Africa Human Organs-on-Chips Market Size by Country
    • 10.3.1 Middle East & Africa Human Organs-on-Chips Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Human Organs-on-Chips Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Human Organs-on-Chips Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Human Organs-on-Chips Market Drivers
  • 11.2 Human Organs-on-Chips Market Restraints
  • 11.3 Human Organs-on-Chips Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Human Organs-on-Chips Industry Chain
  • 12.2 Human Organs-on-Chips Upstream Analysis
  • 12.3 Human Organs-on-Chips Midstream Analysis
  • 12.4 Human Organs-on-Chips Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Organs-on-Chips. Industry analysis & Market Report on Human Organs-on-Chips is a syndicated market report, published as Global Human Organs-on-Chips Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Human Organs-on-Chips market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,780.52
    4,170.78
    5,561.04
    3,246.84
    4,870.26
    6,493.68
    541,314.00
    811,971.00
    1,082,628.00
    289,988.40
    434,982.60
    579,976.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report